share_log

Lifecore Biomedical Analyst Ratings

Benzinga ·  Sep 1, 2023 22:50
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/01/2023 14.07% Stephens & Co. $8 → $9 Maintains Equal-Weight
06/02/2023 39.42% Barrington Research $10 → $11 Maintains Outperform
05/24/2023 26.74% Barrington Research $8 → $10 Maintains Outperform
03/21/2023 1.39% Barrington Research $10 → $8 Maintains Outperform
03/20/2023 1.39% Barrington Research $10 → $8 Maintains Outperform
03/20/2023 -74.65% Stephens & Co. $11 → $2 Downgrades Overweight → Equal-Weight
03/17/2023 39.42% Stephens & Co. → $11 Reiterates → Overweight

What is the target price for Lifecore Biomedical (LFCR)?

The latest price target for Lifecore Biomedical (NASDAQ: LFCR) was reported by Stephens & Co. on September 1, 2023. The analyst firm set a price target for $9.00 expecting LFCR to rise to within 12 months (a possible 14.07% upside). 7 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Lifecore Biomedical (LFCR)?

The latest analyst rating for Lifecore Biomedical (NASDAQ: LFCR) was provided by Stephens & Co., and Lifecore Biomedical maintained their equal-weight rating.

When is the next analyst rating going to be posted or updated for Lifecore Biomedical (LFCR)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lifecore Biomedical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lifecore Biomedical was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.

Is the Analyst Rating Lifecore Biomedical (LFCR) correct?

While ratings are subjective and will change, the latest Lifecore Biomedical (LFCR) rating was a maintained with a price target of $8.00 to $9.00. The current price Lifecore Biomedical (LFCR) is trading at is $7.89, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment